Abhishek Chitnis is a seasoned professional in health economics and outcomes research, currently serving as Senior Director at Insmed Incorporated since November 2023, where a comprehensive research strategy for Brensocatib is being developed. Prior experience includes roles at Biogen as Global HEOR Lead for Neuropsychiatry, where notable contributions led to awards at ISPOR 2023 and AMCP 2023, and as Therapeutic Area Head for Neuromuscular Disease, directing health outcomes projects. At Johnson & Johnson, Chitnis held positions as Director and Associate Director, managing extensive research studies and collaborations across various teams. Earlier experience includes senior roles at Evidera, focusing on health economic projects, and involvement with ISPOR as Network Chair, managing a global network of student chapters. Educational qualifications include a PhD and MS from the University of Houston in Pharmaceutical Health Outcomes and Policy and Pharmacy Administration, respectively.